NSE: GRANULES | BSE: 532482

Falling Comet

Download real time

481.60 -11.60 (-2.35%)

33.20% Fall from 52W High

668.6K NSE+BSE Volume

NSE 08 Jul, 2025 3:31 PM (IST)

11,685.7

Market Cap

High in industry

1.0

Beta 1Year

Average volatility

Dividend

Granules India Ltd. has an upcoming dividend of ₹1.50 per share due on 31 Jul 2025 See details

Granules India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for GRANULES, BSE:532482 Granules India Ltd.

Search Inside the pdf :

Granules India Ltd.

06 Jun 2025

481.60

-2.35%

GRANULES INDIA

Accumulate: Granules India Ltd.

Target

Geojit BNP Paribas

Validation activities have begun in Phase 2, Genome Valley, in this quarter. Also, the company continues to invest in research and development efforts aimed at building a pipeline of high-value molecules, with a focus on backward integration, especially in the oncology and CNS segment. The company has filed its first oncology molecule in this quarter....

Granules India Ltd. has lost -21.83% in the last 6 Months

Granules India Ltd.

28 May 2025

481.60

-2.35%

Broadly in-line quarter; margin resilience led by FDF

Buy: Granules India Ltd.

Target

Motilal Oswal

Granules India (GRAN) delivered a slightly better-than-expected revenue in 4QFY25. However, it reported largely in-line EBITDA/PAT for the quarter.

Granules India Ltd. has lost -21.83% in the last 6 Months

Granules India Ltd.

17 Feb 2025

481.60

-2.35%

GRANULES INDIA

Accumulate: Granules India Ltd.

Target

Geojit BNP Paribas

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

25 Jan 2025

481.60

-2.35%

Finished dosages remain the key earnings driver

Buy: Granules India Ltd.

Target

Motilal Oswal

Granules India (GRAN) delivered better-than-expected revenue, while EBITDA/PAT stood in line for the quarter. The traction in finished dosage (FDF) remained robust for six quarters now.

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

06 Nov 2024

481.60

-2.35%

Plants Resuming Operations and Upcoming Product Launches

Buy: Granules India Ltd.

Target

Sharekhan

Revenues stood at Rs. 957 crore, falling 19% y-o-y and 18% q-o-q, falling 5% short of our estimates.

Granules India Ltd. has an average target of 672.80 from 5 brokers.

Granules India Ltd.

12 Sep 2024

481.60

-2.35%

Gagillapur site under a cloud

Buy: Granules India Ltd.

Motilal Oswal

Granules India (GRAN) was issued a Form 483 with six observations for its Gagillapur site after a recent USFDA inspection.

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

16 Aug 2024

481.60

-2.35%

GRANULES INDIA

Accumulate: Granules India Ltd.

Target

Geojit BNP Paribas

Granules India Ltd. is trading below all available SMAs

Granules India Ltd.

31 Jul 2024

481.60

-2.35%

FD and low base doubled earnings YoY

Buy: Granules India Ltd.

Target

Motilal Oswal

Granules India (GRAN) posted in-line revenue in 1QFY25. However, it delivered better-than-estimated 1QFY25 EBITDA/PAT led by the increased share of formulation sales.